Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Parry

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
The Science of the Total Environment|October 2, 2022
Adaptive growth and acidogenic fermentation performance of haloalkaliphilic bacterial communities enriched from biofilms colonising strongly alkaline and saline bauxite residueYuanying Ma, Fang You, David Parry, et al.
Cancer Management and Research|July 28, 2011
Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care populationNicole M Engel-Nitz, Berhanu Alemayehu, David Parry, et al.
Applied & Translational Genomics|March 4, 2016
Ethics education for clinician-researchers in genetics: The combined approachMa'n Zawati, Eliza Cohen, David Parry, et al.
The New Zealand Medical Journal|August 4, 2009
Interference with the operation of medical devices resulting from the use of radio frequency identification technologyBryan Houliston, David Parry, Craig S Webster, et al.
International Journal of Sports Physiology and Performance|June 11, 2015
Pacing Behavior and Tactical Positioning in 1500-m Short-Track Speed SkatingMarco J Konings, Olaf S Noorbergen, David Parry, et al.
Molecular Cancer Therapeutics|December 29, 2011
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolitesRyan Montano, Injae Chung, Kristen M Garner, et al.
Plos One|November 7, 2014
A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cellsLorena Taricani, Frances Shanahan, Maria-Christina Malinao, et al.
Journal of Continuing Education in Nursing|January 31, 2018
Pilot Study of Educational Gaming to Improve Adherence to an End-Tidal Carbon Dioxide Monitoring ProtocolTaylore D Jansen, Sonja Stutzman, Christine Yu, et al.
Studies in Health Technology and Informatics|August 8, 2013
Opportunistically discovering usability requirements for a clinical handover systemDavid Kaufmann, David Parry, Victoria Carlsen, et al.
Environmental Toxicology and Chemistry|August 15, 2015
Molecular screening of microbial communities for candidate indicators of multiple metal impacts in marine sediments from northern AustraliaAlyssa Cornall, Alea Rose, Claire Streten, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
The Science of the Total Environment|October 2, 2022
Adaptive growth and acidogenic fermentation performance of haloalkaliphilic bacterial communities enriched from biofilms colonising strongly alkaline and saline bauxite residueYuanying Ma, Fang You, David Parry, et al.
Cancer Management and Research|July 28, 2011
Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care populationNicole M Engel-Nitz, Berhanu Alemayehu, David Parry, et al.
Applied & Translational Genomics|March 4, 2016
Ethics education for clinician-researchers in genetics: The combined approachMa'n Zawati, Eliza Cohen, David Parry, et al.
The New Zealand Medical Journal|August 4, 2009
Interference with the operation of medical devices resulting from the use of radio frequency identification technologyBryan Houliston, David Parry, Craig S Webster, et al.
International Journal of Sports Physiology and Performance|June 11, 2015
Pacing Behavior and Tactical Positioning in 1500-m Short-Track Speed SkatingMarco J Konings, Olaf S Noorbergen, David Parry, et al.
Molecular Cancer Therapeutics|December 29, 2011
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolitesRyan Montano, Injae Chung, Kristen M Garner, et al.
Plos One|November 7, 2014
A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cellsLorena Taricani, Frances Shanahan, Maria-Christina Malinao, et al.
Journal of Continuing Education in Nursing|January 31, 2018
Pilot Study of Educational Gaming to Improve Adherence to an End-Tidal Carbon Dioxide Monitoring ProtocolTaylore D Jansen, Sonja Stutzman, Christine Yu, et al.
Studies in Health Technology and Informatics|August 8, 2013
Opportunistically discovering usability requirements for a clinical handover systemDavid Kaufmann, David Parry, Victoria Carlsen, et al.
Environmental Toxicology and Chemistry|August 15, 2015
Molecular screening of microbial communities for candidate indicators of multiple metal impacts in marine sediments from northern AustraliaAlyssa Cornall, Alea Rose, Claire Streten, et al.
Pageof 11